ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 4 – assay validation and quality assurance

26Citations
Citations of this article
77Readers
Mendeley users who have this article in their library.

Abstract

Over the past six years, a diverse group of stakeholders have put forth recommendations regarding the analytical validation of flow cytometric methods and described in detail the differences between cell-based and traditional soluble analyte assay validations. This manuscript is based on these general recommendations as well as the published experience of experts in the area of PNH testing. The goal is to provide practical assay-specific guidelines for the validation of high-sensitivity flow cytometric PNH assays. Examples of the reports and validation data described herein are provided in Supporting Information. © 2017 International Clinical Cytometry Society.

Cite

CITATION STYLE

APA

Oldaker, T., Whitby, L., Saber, M., Holden, J., Wallace, P. K., & Litwin, V. (2018). ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 4 – assay validation and quality assurance. Cytometry Part B - Clinical Cytometry, 94(1), 67–81. https://doi.org/10.1002/cyto.b.21615

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free